To include your compound in the COVID-19 Resource Center, submit it here.

Panel to review Celebrex for juvenile RA

An FDA advisory committee will be asked Wednesday to make recommendations about the use of Pfizer's Celebrex celecoxib to treat pain and inflammation associated with juvenile rheumatoid arthritis

Read the full 280 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE